Swiss biotech firm Timeline attracts major investors such as L’Oréal and Nestlé

Today, January 17, in Lausanne, Timeline, a Swiss consumer health biotechnology company focusing on healthy aging and longevity, announced a successful fundraising of 56 million Swiss Francs (approximately 66 million dollars) in an oversubscribed Series D financing round. This milestone enables Timeline to focus on growth, expand operations, penetrate new markets, and strengthen research and development. 'Oversubscribed' indicates investor demand exceeded the equity offered, signifying strong confidence in Timeline's prospects. This notable funding round marks a significant milestone for the company.

Operating under its parent company, Amazentis, Timeline's flagship is Mitopure®, a clinically validated, proprietary ingredient focused on cellular health, integral to its nutritional supplements and skin care products. With over a decade in aging research, Timeline boasts an extensive background with over 15 years of studies, numerous clinical trials, and more than 50 patents. Since 2019, the company has been supported by Nestlé Health Science as one of its key investors. Anna Mohl, CEO of Nestlé Health Science, noted: "We […] continue to be very impressed with the team and stand behind the exponential potential that the Mitopure technology holds for nutrition to help people age better." The recent financing round, led by BOLD (Business Opportunities for L’Oréal Development), L'Oréal Group's venture capital fund, emphasizes Mitopure®'s role in targeting key cellular longevity pathways, notably rejuvenating mitochondria, the powerhouses of cells. This technology is key to maintaining cellular energy, crucial for muscle strength, cognitive function, immune resilience, skin health, and more, providing a holistic approach to prolonging healthspan. Barbara Lavernos, Deputy Chief Executive Officer in charge of Research, Innovation, and Technology at L’Oréal, shared her vision: "Longevity is about living healthier for longer, and L’Oréal has been working for a decade to understand and anticipate what this could mean for beauty. […] Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty."

Patrick Aebischer, Co-Founder and Chairman of Timeline, expressed his enthusiasm: " This strategic collaboration reflects the breakthrough multidimensional approach that we've always believed is necessary to make meaningful advancements for longevity and healthspan. I want to thank L’Oréal, Nestlé, and our longstanding investors for their commitment to longevity solutions rooted in the highest level of science."

The backing of these industry giants and the newly acquired funds will be allocated to establish Timeline as a premier longevity consumer health brand. Plans include expanding scientific research, diversifying product lines, and extending market reach in the food, beauty, and health sectors.